NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)GLOBAL HEALTH INVESTMENT CORPORATION, founded in 2012, is a major nonprofit in the Health Care sector that reported $204.1M in total revenue in fiscal year 2023. Revenue surged 193% from the prior year, signaling strong growth momentum. The organization ran a surplus of $199.7M, a strong 98% operating margin.
THE CORPORATION IS ORGANIZED AND SHALL BE OPERATED EXCLUSIVELY FOR SOCIAL (CONTINUED SCHEDULE O) (CONTINUED FROM FORM 990, PAGE 1 PART I) WELFARE PURPOSES WITHIN THE MEANING OF SECTION 501(C)(4) OF THE INTERNAL REVENUE CODE OF 1986, AS IT BE AMENDED, INCLUDING THE RELIEF OF THE POOR AND DISTRESSED OR OF THE UNDERPRIVILEGED; THE PROMOTION OF SOCIAL WELFARE AND THE LESSENING OF THE BURDENS OF GOVERNMENT. IN FURTHERANCE OF THESE PURPOSES, THE CORPORATION MAY SEEK WAYS TO PROVIDE AFFORDABLE FINANCING TO SUPPORT THE DEVELOPMENT OF THERAPEUTIC DRUGS & TREATMENTS, VACCINES, PREVENTATIVES, DIAGNOSTICS, AND OTHER TECHNOLOGIES, PRODUCTS OR SERVICES TO ADDRESS GLOBAL HEALTH CHALLENGES, INCLUDING WITHOUT LIMITATION, SUPPORTING THE DEVELOPMENT OF MEDICAL COUNTERMEASURES AND TECHNOLOGIES THAT CAN HELP ADDRESS THREATS TO GLOBAL HEALTH SECURITY, ALL TO PROMOTE THE SOCIAL WELFARE OF ALL POPULATIONS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $204,094,277 | $69,598,791 | +1.9% |
| Expenses | $4,352,803 | $4,087,500 | +0.1% |
| Net Income | $199,741,474 | $65,511,291 | +2.0% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| LABEEB M ABBOUD | CHAIRMAN AND CEO | 40.00 |
Officer
Director
|
$793,636 | $106,972 | $900,608 |
| ARLINA ELMIGER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| PAUL KLINGENSTEIN | DIRECTOR | 1.00 |
Director
|
$28,000 | $0 | $28,000 |
| GEORGE W WELLDE JR | DIRECTOR | 1.00 |
Director
|
$40,000 | $0 | $40,000 |
| EVELYN YANATOS | TREASURER AND SECRETARY | 10.00 |
Officer
|
$0 | $0 | $0 |
| OLAYINKA FAGBAYI | VICE PRESIDENT | 40.00 |
Highest
|
$353,362 | $58,238 | $411,600 |
| JOSEPH LEE | PRINCIPAL | 40.00 |
Highest
|
$231,029 | $38,671 | $269,700 |
| CHARLES JEFFREY PETTY | MANAGING DIRECTOR | 40.00 |
Highest
|
$487,312 | $83,618 | $570,930 |
| DAMIEN ZADOUR SOGHOIAN | VENTURE PARTNER | 40.00 |
Highest
|
$268,765 | $33,629 | $302,394 |
| TRACY SAXTON | VENTURE PARTNER | 40.00 |
Highest
|
$117,562 | $7,926 | $125,488 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $204,094,277 | $4,352,803 | $365,650,768 | $199,741,474 |
| 2022 | $69,598,791 | $4,087,500 | $172,792,060 | $65,511,291 |
| 2021 | $16,847,889 | $1,423,069 | $106,183,994 | $15,424,820 |
| 2020 | $90,877 | $300,982 | $77,518,607 | $-210,105 |
| 2019 | $3,134,337 | $30,539 | $49,978,710 | $3,103,798 |
| 2018 | $2,319,096 | $21,136 | $22,414,736 | $2,297,960 |
Compare GLOBAL HEALTH INVESTMENT CORPORATION with other nonprofits in New York and across the country.